Breaking news

Serena Williams: “I Would Have Been Banned For 20 Years” If I Failed Drug Tests Like Sinner

by News Editor

April 17, 2025

Serena Williams, one of tennis’s most iconic figures, has claimed she would have been handed a 20-year ban and stripped of her Grand Slam titles had she failed drug tests like Jannik Sinner did last year. Serena Williams, who retired in 2022 with 23 Grand Slam singles titles to her name, has long been one of tennis’s most dominant players.

Sinner, the world number one in men’s tennis, accepted a three-month ban earlier this year after the World Anti-Doping Agency (WADA) challenged an independent tribunal’s ruling clearing him of wrongdoing despite testing positive for clostebol, an anabolic steroid. The Italian player maintains his innocence, but the case sparked questions about possible preferential treatment from the authorities. His suspension will be lifted on May 4, 2025.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

In the interview, Williams expressed admiration for Sinner, describing him as a talented player who is “great for the sport.” However, she also highlighted the double standards that seem to exist in tennis, pointing out that had she been in Sinner’s position, the consequences would have been far more severe.

“I love the guy, love this game. He’s great for the sport. I’ve been put down so much, I don’t want to bring anyone down. Men’s tennis needs him,” Williams stated. “But, if I did that, I would have gotten 20 years. Let’s be honest. I would have gotten Grand Slams taken away from me.”

Her comments bring attention to the perceived inconsistencies in the way drug testing and bans are applied in tennis. While Sinner’s suspension remains relatively short, high-profile cases such as Iga Świątek’s one-month ban in November for testing positive for trimetazidine and Simona Halep’s controversial four-year ban for roxadustat use (which was reduced to nine months following an appeal) have ignited further debate.

Williams also shared that she always took extra precautions to ensure she didn’t unknowingly ingest anything that could potentially cause trouble, reflecting the heightened vigilance required by athletes to avoid the risk of unintentional doping violations.

As the sport continues to confront doping issues, questions around consistency and fairness in the application of sanctions remain key talking points.

The Future Forbes Realty Global Properties

SoftBank Shares Tumble Amid Tech Profit Taking And High-Risk AI Investments

Market Sell-Off And Profit Taking

SoftBank Group’s share price plunged over 11% following an overnight sell-off in the U.S. market, as broader profit taking in the technology sector weighed on investor sentiment. Major Asian technology players, including TSMC and Foxconn, experienced similar declines, reflecting a cautious approach among investors despite recent gains.

High-Stakes AI Investments

Despite this short-term volatility, SoftBank’s year-to-date share price surge of approximately 70% is largely fueled by robust investor enthusiasm around its high-risk bets on artificial intelligence. Concerns persist over these aggressive investments, even as the market continues to rally on the promise of AI-driven returns.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Global Technology Landscape

In the broader market, South Korean giants such as Samsung and SK Hynix witnessed modest declines of 1.25% and 2.75%, respectively, following profit taking after surpassing key market valuations. Similarly, overnight in the U.S., semiconductor leader Nvidia fell 3.62%, while Alphabet and Amazon saw declines of 0.79% and 2.5%, respectively.

Long-Term Vision Versus Short-Term Focus

SoftBank CEO Masayoshi Son has been vocal about the transformative potential of artificial intelligence, predicting that the AI revolution could be 50 times larger than the dot-com boom of the 2000s. However, as noted in a recent investor note by Deutsche Bank analyst Peter Milliken, market enthusiasm appears narrowly fixated on short-term momentum rather than a detailed long-term roadmap.

Strategic Asset Reallocation

Adding another layer to the unfolding narrative, SoftBank recently divested a 3.25% stake in Indian eyewear maker Lenskart through its affiliate SVF II Lightbulb (Cayman). The transaction, which involved selling 56.5 million shares at 508.55 Indian rupees each (approximately $5.32 per share), valued the deal at nearly 28.73 billion rupees. Following the sale, SoftBank’s shares traded at 7,377 yen, marking an 11.3% drop.

This dynamic environment underscores the challenges of balancing aggressive, innovation-driven investments with the need for prudent risk management in volatile markets.